Imagine a world where doctors are able to target and remove pathogens, such as harmful cells, bacteria, toxins, and inflammatory cytokines, directly from a patient’s bloodstream. The ability to precisely extract unwanted disease causing substances in this way would revolutionise the treatment of deadly blood-borne diseases, benefiting patients and clinicians around the world. That is MediSieve’s vision for the future of healthcare, and it can be achieved through the process of magnetic blood filtration.
MediSieve plans to use a combination of different magnetic particles to target the various pathogens and cytokines that lead to the symptoms of Sepsis.
The device rapidly reduces the parasitaemia of severe Malaria patients who have been hospitalised and prescribed IV drug treatment.
MediSieve's device captures Leukaemia blasts from the bloodstream in order to reduce the patient's white blood cell count.
The MediSieve System purifies blood by targeting harmful substances with magnetic particles
Paris, 10-13th March 2020
NEC Birmingham, 1-2d April 2020
If you missed it, before Christmas, we announced that Dr George Frodsham, CEO and founder of innova...
Dr George Frodsham, CEO and founder of innovative MedTech company, MediSieve, has been selected as ...